Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3β-related T regulatory cell insufficiency.
Oral administration of bacterial extracts (eg, Broncho-Vaxom (BV)) has been proposed to attenuate asthma through modulating Treg cells. However, the underlying mechanism has not been fully characterized. This study sought to assess the effects of oral administration of BV on GSK-3β expression and Tr...
Main Authors: | Ran Fu, Jian Li, Hua Zhong, Dehong Yu, Xianping Zeng, Mengxia Deng, Yueqi Sun, Weiping Wen, Huabin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3965496?pdf=render |
Similar Items
-
Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP.
by: Michael Roth, et al.
Published: (2017-01-01) -
Allergic BronchoPulmonary Aspergillosis in Nepal
by: Neha Agarwal, et al.
Published: (2014-12-01) -
Allergic BronchoPulmonary Aspergillosis in Nepal
by: Neha Agarwal, et al.
Published: (2014-12-01) -
Allergic Broncho Pulmonary Aspergillosis Complicated by Nocardiosis
by: Brijesh Sharma, et al.
Published: (2012-01-01) -
Retnla overexpression attenuates allergic inflammation of the airway.
by: Mi-Ran Lee, et al.
Published: (2014-01-01)